1. Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption. Haro H, Crawford HC, Fingleton B, MacDougall JR, Shinomiya K, Spengler DM, Matrisian LM (2000) J Clin Invest 105(2): 133-41
    › Primary publication · 10642591 (PubMed) · PMC377425 (PubMed Central)
  2. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis. Powell WC, Fingleton B, Wilson CL, Boothby M, Matrisian LM (1999) Curr Biol 9(24): 1441-7
    › Primary publication · 10607586 (PubMed)
  3. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Crawford HC, Fingleton BM, Rudolph-Owen LA, Goss KJ, Rubinfeld B, Polakis P, Matrisian LM (1999) Oncogene 18(18): 2883-91
    › Primary publication · 10362259 (PubMed)
  4. Matrilysin in early stage intestinal tumorigenesis. Fingleton BM, Heppner Goss KJ, Crawford HC, Matrisian LM (1999) APMIS 107(1): 102-10
    › Primary publication · 10190286 (PubMed)